Collaborations
NurExone pursues strategic collaborations, licensing opportunities, and development partnerships to expand the potential of its ExoTherapy platform across additional indications, delivery technologies, manufacturing capabilities, and regenerative medicine applications.
Current collaborations include:








Collaboration with Professor Michael Belkin at Sheba Medical Center:
Building on earlier ExoPTEN preclinical studies conducted at the Goldschleger Eye Institute at Sheba Medical Center, a larger animal study is now underway to further assess ExoPTEN’s potential in optic nerve repair, nerve preservation, and functional visual recovery.

